Registered Nurse in Philadelphia, NY Accepting Medicare

1 Registered Nurse nurses found. Showing 1 - 1

Mrs. Kathleen Rose Zeltmann, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3 Sand St, Philadelphia, NY 13673 Phone: 315-642-3432    Fax: 315-642-5650

News Archive

Pediatrician offers ten Halloween safety tips

Halloween is approaching, and many parents may wonder if trick-or-treating is safe. Dr. Luz Adriana Matiz, pediatrician at NewYork-Presbyterian/Morgan Stanley Children's Hospital, suggests that with a few precautions, Halloween can be a happy and safe occasion for all. Dr. Matiz suggests that children limit trick-or-treating to familiar neighborhoods and neighbors.

40% of gay men with HIV don't know they are infected

A survey of gay men questioned at gay venues in cities across the UK has found that most of those with undiagnosed HIV infection assumed they were HIV negative. Most of them had previously tested negative and thought they were in the clear. It's feared these men could unknowingly be putting others at risk. These are the findings of a study led by Dr Lisa Williamson at the MRC Social and Public Health Sciences Unit in Glasgow and published in the journal, AIDS.

aPKC enzyme tells stem cells which way to divide

Driving Miranda, a protein in fruit flies crucial to switch a stem cell's fate, is not as complex as biologists thought, according to University of Oregon biochemists. They've found that one enzyme (aPKC) stands alone and acts as a traffic cop that directs which roads daughter cells will take.

Empa researchers investigate the safety of graphene for humans

Graphene, a single layer of hexagonally arranged carbon atoms, is regarded as the miracle material of the future: it is flexible, transparent, strong, can assume different electrical properties and has the highest thermal conductivity of all known materials.

Phase II data on Genetic Immunity's DermaVir vaccine to be presented at XVIII International AIDS Conference

Genetic Immunity, a US/Hungarian biopharmaceutical company developing nanomedicine-based immunotherapies for HIV/AIDS and other chronic diseases, is releasing Phase II data on the Company's novel DermaVir therapeutic vaccine for HIV/AIDS during the XVIII International AIDS Conference this week in Vienna, Austria. DermaVir, the first dendritic cell-targeting topical HIV vaccine candidate, employs nanotechnology to induce multi-faceted and long-lived immune responses capable of eliminating HIV infected cells.

Read more Medical News

› Verified 1 days ago